Rock Springs Capital Management LP Q4 2022 Filing

Filed February 14, 2023

Portfolio Value

$4.2B

Holdings

120

Report Date

Q4 2022

Filing Type

13F-HR

All Holdings (120 positions)

#	Stock	Shares	Value	% Portfolio
101	—THESEUS PHARMACEUTICALS INC	437,329	$2.0M	0.05%
102	NKTXNKARTA INC	393,389	$2.0M	0.05%
103	OKURRENEO PHARMACEUTICALS INC	1,143,185	$2.0M	0.05%
104	AUPHAURINIA PHARMACEUTICALS INC	479,540	$2.0M	0.05%
105	FULCFULCRUM THERAPEUTICS INC	384,590	$2.0M	0.05%
106	NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC	1,000,000	$1.0M	0.02%
107	FATEFATE THERAPEUTICS INC	110,000	$1.0M	0.02%
108	EPIEURESSA PHARMA INC	524,944	$1.0M	0.02%
109	SPROSPERO THERAPEUTICS INC	669,533	$1.0M	0.02%
110	SPRBSPRUCE BIOSCIENCES INC	1,622,689	$1.0M	0.02%
111	OVASUSDTEMPEST THERAPEUTICS INC	823,654	$947K	0.02%
112	CGENCOMPUGEN LTD	1,289,990	$923K	0.02%
113	—VINCERX PHARMA INC	891,719	$910K	0.02%
114	GOSSGOSSAMER BIO INC	376,048	$816K	0.02%
115	TLPHACELRX PHARMACEUTICALS INC	316,460	$715K	0.02%
116	NVRO 2.75 04/01/25NEVRO CORP	500,000	$459K	0.01%
117	APLTAPPLIED THERAPEUTICS INC	596,680	$453K	0.01%
118	BCELATRECA INC	362,530	$290K	0.01%
119	HUMHUMANA INC	426,500	$218K	0.01%
120	UNHUNITEDHEALTH GROUP INC	270,000	$143K	0.00%

PreviousPage 2 of 2